Browsing by 저자 : 김태원
전체 결과 38건 중 1-38 번을 표시중입니다.
- 1 Article A phase 1 dose-escalation and dose-expansion study to assess the safety and efficacy of CKD-516, a novel vascular disrupting agent, in combination with Irinotecan in patients with previously treated metastatic colorectal cancer 김승태 ; 김정은 ; 김태원 ; et al 2021
- 2 Article A Phase II Study of Avelumab Monotherapy in Patients with Mismatch Repair-Deficient/Microsatellite Instability-High or POLE-Mutated Metastatic or Unresectable Colorectal Cancer 김선영 ; 김열홍 ; 김정은 ; et al 2020
- 3 Article A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases 김성금 ; 김태원 ; 박용숙 ; et al 2020
- 4 Article ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma 김규표 ; 김승태 ; 김유정 ; et al 2021
- 5 Article Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT Trial 김태원 ; Andre T ; Aranda E ; et al 2020
- 6 Article Bevacizumab plus capecitabine as later-line treatment for patients with metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines 김규표 ; 김선영 ; 김정은 ; et al 2021
-
7
Dissertation
BRAF V600E 돌연변이 진행성 직결장암 환자들의 임상 및 병리학적 특성
천재경
2017
- 8 Article Chemosensitivity to HM90822, a novel synthetic IAP antagonist, is determined by p-AKT-inducible XIAP phosphorylation in human pancreatic cancer cells 강종훈 ; 고동인 ; 김도연 ; et al 2020
- 9 Article Clinical characteristics and survival of colorectal cancer patients in Korea stratified by age 강미연 ; 김종광 ; 김태원 ; et al 2021
- 10 Article Controversial Issues Regarding Obligatory Adjuvant Chemotherapy for Stage IIIA Colon Cancer 김진천 ; 김찬욱 ; 김태원 ; et al 2020
- 11 Article Current challenges in the implementation of precision oncology for the management of metastatic colorectal cancer 김선영 ; 김태원 2020
- 12 Article Effectiveness of Combining Bevacizumab With First-Line Chemotherapy Regimens for Metastatic Colorectal Cancer in Real-World Practice 김선영 ; 김정은 ; 김지원 ; et al 2021
- 13 Article Efficacy of Panitumumab and Cetuximab in Patients with Colorectal Cancer Previously Treated with Bevacizumab; a Combined Analysis of Individual Patient Data from ASPECCT and WJOG6510G 김태원 ; Daisuke Sakai ; Hiroya Taniguchi ; et al 2020
- 14 Article Evaluating waiting time with real-world health information in a high-volume cancer center 김규표 ; 김정은 ; 김태원 ; et al 2020
- 15 Article Feasibility of a Hybrid Risk-Adapted Monitoring System in Investigator-Sponsored Trials in Cancer 김신애 ; 김윤옥 ; 김윤정 ; et al 2021
- 16 Article Feasibility of a Hybrid Risk-Adapted Monitoring System in Investigator-Sponsored Trials in Cancer 김신애 ; 김윤옥 ; 김윤정 ; et al 2021
- 17 Article Frequency of S492R mutations in the epidermal growth factor receptor: analysis of plasma DNA from patients with metastatic colorectal cancer treated with panitumumab or cetuximab monotherapy 김태원 ; Agnes Ang ; Anne Thomas ; et al 2020
- 18 Article Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial 김태원 ; Benny Vittrup Jensen ; Christelle De La Fouchardier ; et al 2021
- 19 Article High prevalence of TP53 loss and whole-genome doubling in early-onset colorectal cancer 김선영 ; 김정은 ; 김종일 ; et al 2021
- 20 Article How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare Cancers 구하영 ; 김규표 ; 김선영 ; et al 2020
- 21 Article Immuno-genomic classification of colorectal cancer organoids reveals cancer cells with intrinsic immunogenic properties associated with patient survival 김덕훈 ; 김민서 ; 김지혜 ; et al 2021
- 22 Article Impact of UGT1A1 genotype on the efficacy and safety of irinotecan-based chemotherapy in metastatic colorectal cancer 김태원 ; 박영석 ; 안중배 ; et al 2021
- 23 Article Inhibition of JAK1/2 can overcome EGFR-TKI resistance in human NSCLC 고동인 ; 공지희 ; 기소영 ; et al 2020
- 24 Article KRAS(G12C) Inhibition with Sotorasib in Advanced Solid Tumors June Kim ; 김태원 ; Adrian Sacher ; et al 2020
- 25 Article Lateral lymph node and its association with distant recurrence in rectal cancer: A clue of systemic disease 김영일 ; 김종범 ; 김진천 ; et al 2020
- 26 Article Long-term oncologic and complication outcomes in anal cancer patients treated with radiation therapy 주지현 ; 박진홍 ; 윤상민 ; et al 2020
- 27 Article Longitudinal change of genetic variations in cetuximab-treated metastatic colorectal cancer 김권일 ; 김선영 ; 김정은 ; et al 2021
- 28 Article Management of isolated para-aortic lymph node recurrence after surgery for colorectal cancer 김영일 ; 김진천 ; 김태원 ; et al 2020
- 29 Article Olaparib with or without bevacizumab or bevacizumab and 5-fluorouracil in advanced colorectal cancer: Phase III LYNK-003 김태원 ; Ellen B Gurary ; Julien Taieb ; et al 2021
- 30 Article Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck 김태원 ; B Keam ; C Belka ; et al 2021
- 31 Article Patterns of recurrence in patients with curative resected rectal cancer according to different chemoradiotherapy strategies: Does preoperative chemoradiotherapy lower the risk of peritoneal recurrence? 김규표 ; 김선영 ; 김정은 ; et al 2020
- 32 Article Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer 김태원 ; Benny Vittrup Jensen ; Christelle de la Fouchardiere ; et al 2020
- 33 Article Proton Pump Inhibitor Use and the Efficacy of Chemotherapy in Metastatic Colorectal Cancer: A Post Hoc Analysis of a Randomized Phase III Trial (AXEPT) 강준호 ; 김선영 ; 김태원 ; et al 2021
- 34 Article Real-World Outcomes of Pazopanib Treatment in Korean Patients with Advanced Soft Tissue Sarcoma: A Multicenter Retrospective Cohort Study 김정은 ; 김지형 ; 김태원 ; et al 2020
- 35 Article The Asian Approach to the Management of Gastrintestinal Cancer Patients During the COVID-19 Pandemic Era 김태원 ; 형제원 2020
-
36
Dissertation
근치적 수술을 시행받은 2, 3기 직장암 환자에서 현미부수체 불안정성의 예후인자로서의 역할
오충렬
2017
-
37
dissertation
대장암 세포에서 Notch1 활성 억제를 통한 세툭시맙 반응성 개선
최수은
2022
-
38
dissertation
전이성 직결장암 환자에서 항암치료 중 신체 구성의 변화와 예후
정혜현
2022
1